Last reviewed · How we verify
Usual brand cigar
Usual brand cigar is a tobacco product that contains nicotine, which acts on nicotinic acetylcholine receptors in the brain.
Usual brand cigar is a tobacco product that contains nicotine, which acts on nicotinic acetylcholine receptors in the brain. Used for Smoking cessation.
At a glance
| Generic name | Usual brand cigar |
|---|---|
| Also known as | UB |
| Sponsor | Ohio State University Comprehensive Cancer Center |
| Target | nicotinic acetylcholine receptors |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Nicotine binds to nicotinic acetylcholine receptors, stimulating the release of dopamine and other neurotransmitters, which can lead to feelings of pleasure and reward. This can lead to physical dependence and addiction. The effects of nicotine on the brain can also lead to changes in mood, attention, and other cognitive processes.
Approved indications
- Smoking cessation
Common side effects
- Nicotine withdrawal symptoms
- Cardiovascular disease
- Lung cancer
- Respiratory disease
Key clinical trials
- Addiction Potential of Very Low Nicotine Filtered Little Cigars (PHASE4)
- Addiction and Behavior Related to Menthol Cigarette Substitutes (NA)
- Reduced Nicotine Content Cigarettes and Tobacco Switching Behaviors (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Usual brand cigar CI brief — competitive landscape report
- Usual brand cigar updates RSS · CI watch RSS
- Ohio State University Comprehensive Cancer Center portfolio CI